Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
700.04
662.44
647.21
683.26
748.46
676.04
538.46
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
700.04
662.44
647.21
683.26
748.46
676.04
538.46
Raw Material Cost
286.36
291.52
244.54
225.65
227.16
191.44
201.67
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
132.13
99.89
84.34
76.45
67.86
65.34
58.03
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
11.16
15.33
9.24
5.41
5.05
0.57
0.80
Selling and Distribution Expenses
241.95
201.09
234.88
260.64
319.69
312.47
205.50
Other Expenses
-9.88
-7.01
-4.99
-4.27
-4.15
-3.65
-3.33
Total Expenditure (Excl Depreciation)
572.83
537.77
523.07
525.41
578.27
533.34
432.66
Operating Profit (PBDIT) excl Other Income
127.2
124.7
124.1
157.89999999999998
170.2
142.7
105.8
Other Income
83.80
17.39
16.06
12.51
14.35
6.62
6.76
Operating Profit (PBDIT)
303.96
216.66
194.61
222.01
227.60
178.21
131.25
Interest
11.16
15.33
9.24
5.41
5.05
0.57
0.80
Exceptional Items
-20.67
-6.85
-6.07
6.24
-7.11
-1.94
-0.17
Gross Profit (PBDT)
413.68
370.92
402.67
457.61
521.30
484.59
336.79
Depreciation
96.73
78.79
63.22
55.83
48.79
22.80
19.63
Profit Before Tax
175.40
115.69
116.09
167.02
166.66
152.91
110.65
Tax
17.35
12.01
2.66
26.27
23.94
21.98
15.50
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
200.70
162.90
161.58
170.80
165.14
131.39
96.91
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
200.70
162.90
161.58
170.80
165.14
131.39
96.91
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.09
-0.85
-0.40
0.43
-0.19
-0.43
0.48
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
200.79
162.05
161.18
171.23
164.95
130.96
97.40
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,260.08
1,192.31
1,087.89
986.31
873.95
756.62
660.79
Earnings per share (EPS)
0.63
0.5
0.49
0.52
0.5
0.4
0.3
Diluted Earnings per share
0.63
0.5
0.49
0.52
0.5
0.4
0.3
Operating Profit Margin (Excl OI)
17.63%
18.19%
17.82%
22.49%
21.97%
22.01%
19.47%
Gross Profit Margin
38.87%
29.36%
27.7%
32.61%
28.79%
25.99%
24.2%
PAT Margin
28.67%
24.59%
24.97%
25.0%
22.06%
19.44%
18.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 5.68% vs 2.35% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 23.95% vs 0.50% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 10.49% vs 11.59% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is -26.80% vs 66.30% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has fallen from Dec 2023
Compare Annual Results Of Zhejiang Cheng Yi Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
700.04
0
700.04
Other Operating Income
0.00
0.00
0.00
Total Operating income
700.04
0
700.04
Raw Material Cost
286.36
0
286.36
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
132.13
0
132.13
Power Cost
0
0
0.00
Manufacturing Expenses
11.16
0
11.16
Selling and Distribution Expenses
241.95
0
241.95
Other Expenses
-9.88
0.00
-9.88
Total Expenditure (Excl Depreciation)
572.83
0
572.83
Operating Profit (PBDIT) excl Other Income
127.20
0.00
127.20
Other Income
83.80
0
83.80
Operating Profit (PBDIT)
303.96
0
303.96
Interest
11.16
0
11.16
Exceptional Items
-20.67
0
-20.67
Gross Profit (PBDT)
413.68
0
413.68
Depreciation
96.73
0
96.73
Profit Before Tax
175.40
0
175.40
Tax
17.35
0
17.35
Provisions and contingencies
0
0
0.00
Profit After Tax
200.70
0
200.70
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
200.70
0
200.70
Share in Profit of Associates
0
0
0.00
Minority Interest
0.09
0
0.09
Other related items
0.00
0.00
0.00
Consolidated Net Profit
200.79
0
200.79
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,260.08
0
1,260.08
Earnings per share (EPS)
0.63
0
0.63
Diluted Earnings per share
0.63
0
0.63
Operating Profit Margin (Excl OI)
17.63%
0%
0.00
17.63%
Gross Profit Margin
38.87%
0%
0.00
38.87%
PAT Margin
28.67%
0%
0.00
28.67%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 70.00 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 5.68% vs 2.35% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 20.08 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 23.95% vs 0.50% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 22.02 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 10.49% vs 11.59% in Dec 2023
Annual - Interest
Interest 1.12 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -26.80% vs 66.30% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.63%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has fallen from Dec 2023






